Lumos Pharma (LUMO) Institutional Ownership → He cracked the code to crypto… (From Weiss Ratings) (Ad) Free LUMO Stock Alerts $2.34 -0.21 (-8.24%) (As of 09:44 AM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Lumos Pharma (NASDAQ:LUMO)CurrentInstitutional OwnershipPercentage33.99%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$172.63KNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$594.83K Get LUMO Insider Trade Alerts Want to know when executives and insiders are buying or selling Lumos Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LUMO Institutional Buying and Selling by Quarter Ad Banyan Hill PublishingForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadThe AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016.Get the full story here. Lumos Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/15/2024Blackstone Inc.326,552$1.04M0.0%-30.2%4.128% 2/6/2024 Private Advisor Group LLC16,013$51K0.0%-20.0%0.202% 11/7/2023 Greenwich Wealth Management LLC76,341$252K0.0%+55.8%0.961% 11/3/2023 Private Advisor Group LLC20,013$66K0.0%+42.8%0.252% 10/27/2023 Marquette Asset Management LLC25,760$85K0.0%-17.1%0.324% 10/27/2023 Acuitas Investments LLC125,242$413K0.2%-18.6%1.577% Get the Latest News and Ratings for LUMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lumos Pharma and its competitors with MarketBeat's FREE daily newsletter. 8/10/2023 Private Advisor Group LLC14,013$46K0.0%-30.0%0.172% 7/31/2023 Greenwich Wealth Management LLC49,002$162K0.0%+63.2%0.600% 5/1/2023 Marquette Asset Management LLC31,088$103K0.0%+47.9%0.379% 4/24/2023 Greenwich Wealth Management LLC30,028$99K0.0%N/A0.366% 2/10/2023K2 Principal Fund L.P.15,836$57K0.0%-71.7%0.189% 1/18/2023 Private Advisor Group LLC20,013$72K0.0%+17.6%0.238% 1/12/2023 Marquette Asset Management LLC21,020$76K0.0%+57.9%0.250% 10/14/2022 Private Advisor Group LLC17,013$151K0.0%-37.0%0.203% 8/15/2022Opaleye Management Inc.21,520$166K0.1%N/A0.257% 7/26/2022 Key Financial Inc10,916$84K0.0%N/A0.130% 7/22/2022Urban Wealth Management LLC3,490$27K0.1%N/A0.042% 2/15/2022Lion Point Capital LP51,205$354K0.1%-87.4%0.613% 2/4/2022 Envestnet Asset Management Inc.10,368$72K0.0%N/A0.124% 2/2/2022PVG Asset Management Corp10,175$71K0.3%N/A0.122% 1/14/2022Investors Financial Group LLC30,600$212K0.1%-11.6%0.366% 11/15/2021Minerva Advisors LLC34,015$321K0.2%N/A0.407% 11/12/2021 Renaissance Technologies LLC286,412$2.72M0.0%-6.3%3.427% 11/12/2021 Connor Clark & Lunn Investment Management Ltd.33,427$318K0.0%+4.7%0.400% 10/21/2021Investors Financial Group LLC34,600$329K0.2%+16.9%0.414% 10/12/2021 Marquette Asset Management LLC13,234$126K0.0%+48.4%0.158% 8/17/2021Price T Rowe Associates Inc. MD159,595$1.59M0.0%N/A1.910% 8/16/2021Opaleye Management Inc.382,000$3.82M0.6%+1.4%4.571% 8/16/2021State Street Corp11,237$112K0.0%N/A0.134% 8/13/2021 Renaissance Technologies LLC305,757$3.06M0.0%-8.0%3.659% 8/12/2021 Dimensional Fund Advisors LP39,405$392K0.0%-5.0%0.472% 8/12/2021 Connor Clark & Lunn Investment Management Ltd.31,938$317K0.0%-4.1%0.382% 7/19/2021 Marquette Asset Management LLC8,919$89K0.0%N/A0.107% 5/18/2021Opaleye Management Inc.376,900$4.41M0.6%+34.0%4.516% 5/17/2021Deerfield Management Company L.P. Series C373,117$4.37M0.1%-60.1%4.471% 5/14/2021 Dimensional Fund Advisors LP41,459$485K0.0%-4.8%0.497% 5/13/2021 Renaissance Technologies LLC332,419$3.89M0.0%+7.6%3.983% 5/12/2021Northern Trust Corp2,960$35K0.0%-75.5%0.035% 5/11/2021 Acadian Asset Management LLC5,879$69K0.0%+65.0%0.070% 5/7/2021 BlackRock Inc.71,078$831K0.0%+2.9%0.853% Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (Ad)The AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016.Get the full story here.4/14/2021Investors Financial Group LLC29,200$342K0.2%+60.4%0.350% 2/22/2021 West Financial Advisors LLC784$28K0.0%N/A0.009% 2/18/2021Verition Fund Management LLC9,835$351K0.0%N/A0.119% 2/16/2021One68 Global Capital LLC5,855$209K0.4%N/A0.071% 2/16/2021ExodusPoint Capital Management LP37,203$1.33M0.0%N/A0.448% 2/12/2021Opaleye Management Inc.281,287$10.05M1.3%+16.8%3.390% 2/11/2021Northern Trust Corp12,081$432K0.0%+292.0%0.146% 2/10/2021 Renaissance Technologies LLC308,812$11.03M0.0%+0.9%3.722% 2/9/2021 Wells Fargo & Company MN117,660$4.20M0.0%+1.1%1.418% 2/9/2021 Bank of New York Mellon Corp17,493$625K0.0%N/A0.211% 1/21/2021 Foster Group Inc.7,283$221K0.0%N/A0.088% 1/19/2021Investors Financial Group LLC18,200$650K0.4%-16.4%0.219% 11/12/2020 Connor Clark & Lunn Investment Management Ltd.31,978$442K0.0%-12.5%0.386% 11/10/2020 Texas Yale Capital Corp.16,000$221K0.0%+6.7%0.193% 11/9/2020 Acadian Asset Management LLC5,161$71K0.0%-85.7%0.062% 11/5/2020 Wells Fargo & Company MN116,392$1.61M0.0%+3.7%1.403% 10/14/2020Investors Financial Group LLC21,766$301K0.2%-81.1%0.262% 9/15/2020Two Sigma Advisers LP13,298$219K0.0%-5.0%0.160% 8/14/2020Logos Global Management LP50,000$825K0.2%N/A0.606% 8/14/2020Jefferies Group LLC120,651$1.99M0.0%+13.0%1.462% (Data available from 1/1/2016 forward) LUMO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LUMO shares? During the previous two years, 9 institutional investors and hedge funds held shares of Lumos Pharma. The most heavily invested institutionals were Blackstone Inc. ($1.04M), Acuitas Investments LLC ($413K), Greenwich Wealth Management LLC ($252K), Opaleye Management Inc. ($166K), Marquette Asset Management LLC ($85K), Key Financial Inc ($84K), and K2 Principal Fund L.P. ($57K).Learn more on LUMO's institutional investors. What percentage of Lumos Pharma stock is owned by institutional investors? 33.99% of Lumos Pharma stock is owned by institutional investors. Learn more on LUMO's institutional investor holdings. Which institutional investors have been buying Lumos Pharma stock? The following institutional investors have purchased Lumos Pharma stock in the last 24 months: Greenwich Wealth Management LLC ($76.34K), Opaleye Management Inc. ($21.52K), Marquette Asset Management LLC ($17.77K), Key Financial Inc ($10.92K), Private Advisor Group LLC ($9K), and Urban Wealth Management LLC ($3.49K). How much institutional buying is happening at Lumos Pharma? Institutional investors have bought a total of 139,040 shares in the last 24 months. This purchase volume represents approximately $620.63K in transactions. Which Lumos Pharma major shareholders have been selling company stock? The following institutional investors have sold Lumos Pharma stock in the last 24 months: Blackstone Inc. ($141.59K), K2 Principal Fund L.P. ($40.03K), Acuitas Investments LLC ($28.63K), Private Advisor Group LLC ($20K), and Marquette Asset Management LLC ($5.33K). How much institutional selling is happening at Lumos Pharma? Institutional investors have sold a total of 235,576 shares in the last 24 months. This volume of shares sold represents approximately $827.84K in transactions. Related Companies: Oncternal Therapeutics Institutional Ownership Iterum Therapeutics Institutional Ownership Forte Biosciences Institutional Ownership Lisata Therapeutics Institutional Ownership TherapeuticsMD Institutional Ownership Bullfrog AI Institutional Ownership Biora Therapeutics Institutional Ownership Cumberland Pharmaceuticals Institutional Ownership Lipocine Institutional Ownership RenovoRx Institutional Ownership This page (NASDAQ:LUMO) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldBiden to Drop BOMBSHELL June 13th?Paradigm PressForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill Publishingis this a buy and hold stock?Tips4TradersWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lumos Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.